Clinical Trial Update: IVF Outcome Following Treatment With Ulipristal Acetate for Myomatous Uterus After at Least One IVF Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update examining outcomes of Ulipristal Acetate treatment for women with uterine fibroids after at least one IVF failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Uterine Fibroids

Drugs mentioned

• Ulipristal acetate (ulipristal acetate)

Snippet

Sponsor: Sheba Medical Center | Conditions: Women With Leiomyoma After at Least One Unsuccessful IVF Treatment | Phase 4 | Status: UNKNOWN